Ma Dan, Guan Baoyi, Song Luxia, Liu Qiyu, Fan Yixuan, Zhao Lin, Wang Tongxin, Zhang Zihao, Gao Zhuye, Li Siming, Xu Hao
Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Graduate School, Beijing University of Chinese Medicine, Beijing, China.
Front Cardiovasc Med. 2021 Aug 25;8:734514. doi: 10.3389/fcvm.2021.734514. eCollection 2021.
Exosomes in cardiovascular diseases (CVDs) have become an active research field with substantial value and potential. Nevertheless, there are few bibliometric studies in this field. We aimed to visualize the research hotspots and trends of exosomes in CVDs using a bibliometric analysis to help understand the future development of basic and clinical research. The articles and reviews regarding exosomes in the CVDs were culled from the Web of Science Core Collection, and knowledge maps were generated using CiteSpace and VOSviewer software. A total of 1,039 articles were included. The number of exosome articles in the CVDs increased yearly. These publications came from 60 countries/regions, led by the US and China. The primary research institutions were Shanghai Jiao Tong University and Nanjing Medical University. was the journal and co-cited journal with the most studies. We identified 473 authors among which Lucio Barile had the most significant number of articles and Thery C was co-cited most often. After analysis, the most common keywords are myocardium infarction, microRNA and mesenchymal stem cells. Ischemic heart disease, pathogenesis, regeneration, stem cells, targeted therapy, biomarkers, cardiac protection, and others are current and developing areas of study. We identified the research hotspots and trends of exosomes in CVDs using bibliometric and visual methods. Research on exosomes is flourishing in the cardiovascular medicine. Regenerative medicine, exosome engineering, delivery vehicles, and biomarkers will likely become the focus of future research.
Front Cardiovasc Med. 2021-8-25
Vasc Health Risk Manag. 2024
Am J Transl Res. 2023-12-15
Front Cardiovasc Med. 2022-12-20
Medicine (Baltimore). 2024-7-12
Front Med (Lausanne). 2025-5-30
Front Mol Biosci. 2025-5-9
Front Cardiovasc Med. 2025-4-14
Stem Cell Reports. 2021-6-8
Nature. 2021-4
Theranostics. 2021-2-15
Front Cell Dev Biol. 2021-1-12